“We …feel this is a real game changer” Dr. Pridgen With 90% of the data from their big Fibromyalgia antiviral study in, Dr. William “Skip” Pridgen reported in the Tuscaloosa News that the results were ‘very positive’....
Treatment Chimerix, the manufacturer of the herpesvirus drug, brincidofovir (formerly known as CMX001), recently went public and the guess is that they’re very confident about getting FDA approval. On your alternative treatments page you note brincidofovir...
Fibromyalgia, not chronic fatigue syndrome, is going be the recipient of the first large, multi-center antiviral treatment trial. In an entirely new approach to FM, Dr. Skip Pridgen is using a novel two-drug approach, to smother the herpesviruses he believes are...
